Published in Transplant Rev (Orlando) on April 01, 2008
Dynamic regulation of barrier integrity of the corneal endothelium. Optom Vis Sci (2010) 1.06
Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur J Immunol (2011) 0.93
Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol (2013) 0.88
Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model. Cornea (2012) 0.83
Evaluation of corneal graft survival in mice model. Int J Ophthalmol (2013) 0.79
Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist. PLoS One (2014) 0.77
CD154 blockade modulates the ratio of Treg to Th1 cells and prolongs the survival of allogeneic corneal grafts in mice. Exp Ther Med (2014) 0.76
The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov (2010) 2.23
Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. Br J Ophthalmol (2010) 1.96
Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis (2002) 1.42
A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis. Br J Ophthalmol (2011) 1.39
Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am J Ophthalmol (2006) 1.26
Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood (2005) 1.24
Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol (2006) 1.24
Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology (2006) 1.18
Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol (2005) 1.15
Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci (2004) 1.13
Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res (2004) 1.03
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunol Immunother (2013) 1.01
Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum (2002) 1.01
Oscillations in the immune system. Immunol Rev (2007) 1.00
Reconstruction of cell population dynamics using CFSE. BMC Bioinformatics (2007) 0.99
Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci (2003) 0.99
Feedback control of T-cell receptor activation. Proc Biol Sci (2004) 0.98
T-lymphocyte invasiveness: control by voltage-gated Na+ channel activity. FEBS Lett (2004) 0.98
3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. Invest Ophthalmol Vis Sci (2011) 0.93
Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur J Immunol (2011) 0.93
Gene delivery by dendrimers operates via different pathways in different cells, but is enhanced by the presence of caveolin. J Immunol Methods (2006) 0.93
A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Eur J Immunol (2004) 0.92
Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci (2002) 0.92
Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction. Exp Eye Res (2005) 0.90
Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry. Bioorg Med Chem Lett (2011) 0.90
Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol (2005) 0.90
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood (2005) 0.89
Induction of replication in human corneal endothelial cells by E2F2 transcription factor cDNA transfer. Invest Ophthalmol Vis Sci (2005) 0.89
Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunol Immunother (2007) 0.88
Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol (2013) 0.88
Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol (2014) 0.87
Effect of glaucoma on corneal graft survival according to indication for penetrating keratoplasty. Am J Ophthalmol (2010) 0.86
Regulation of rat and human T-cell immune response by pharmacologically modified dendritic cells. Transplantation (2009) 0.86
Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles. Ultrasound Med Biol (2005) 0.86
Gene therapy for transplantation with viral vectors--how much of the promise has been realised? Expert Opin Biol Ther (2006) 0.84
Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET. J Nucl Med (2011) 0.84
A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer. Cancer Immunol Immunother (2004) 0.83
Targeting gene delivery to activated vascular endothelium using anti E/P-Selectin antibody linked to PAMAM dendrimers. J Immunol Methods (2009) 0.83
Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk. Am J Ophthalmol (2010) 0.83
Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats. FASEB J (2013) 0.82
Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol Ther (2005) 0.82
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis. Arthritis Rheum (2011) 0.82
Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection. Biomaterials (2013) 0.82
Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival. Transplantation (2008) 0.81
Tolerant T cells display impaired trafficking ability. Eur J Immunol (2005) 0.81
Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest Ophthalmol Vis Sci (2006) 0.81
Effect of overexpressing the transcription factor E2F2 on cell cycle progression in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci (2004) 0.80
Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. Nucleic Acids Res (2009) 0.80
Xenon Treatment Protects against Remote Lung Injury after Kidney Transplantation in Rats. Anesthesiology (2015) 0.77
Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasia. J Heart Lung Transplant (2007) 0.77
Knockdown of mouse VCAM-1 by vector-based siRNA. Transpl Immunol (2006) 0.77
Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism. Cytotherapy (2011) 0.77
Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest. Immunology (2013) 0.77
A novel strategy for preserving renal grafts in an ex vivo setting: potential for enhancing the marginal donor pool. FASEB J (2013) 0.76
Transfection of indoleamine 2,3 dioxygenase in primary endothelial cells. Methods Mol Biol (2010) 0.76
Changing viral tropism using immunoliposomes alters the stability of gene expression: implications for viral vector design. Mol Med (2007) 0.75
Macromolecular synthetic biomaterials for delivery of therapeutics. Macromol Rapid Commun (2010) 0.75
Novel triblock oligopeptides as efficient nonviral vectors: characterisation and further insights. Macromol Rapid Commun (2010) 0.75
Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva. Br J Ophthalmol (2010) 0.75
Longitudinal Changes to Tight Junction Expression and Endothelial Cell Integrity in a Mouse Model of Sterile Corneal Inflammation. Invest Ophthalmol Vis Sci (2016) 0.75
Gene therapy for clinical transplantation: where do we stand in 2006? Discov Med (2006) 0.75